# Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-3-trials-of-ixekizumab-in-moderate-to-severe-plaque-psoriasis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kenneth B. Gordon,Andrew Blauvelt,Kim Papp,Richard G. Langley,Thomas A. Luger,Mamitaro Ohtsuki,Kristian Reich,David A. Amato,Susan Ball,Daniel Braun,Gregory S. Cameron,J. Erickson,Robert J. Konrad,Talia M. Muram,Brian J. Nickoloff,Olawale Osuntokun,Roberta J. Secrest,Fangyi Zhao,Lotus Mallbris,Craig L. Leonardi |
| Citations | 845 |
| DOI | 10.1056/nejmoa1512711 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1512711?articleTools=true |
| OpenAlex ID | https://openalex.org/W2418506270 |
| PMID | 27299809 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Thomas A. Luger](https://scholariq.org/researchers/thomas-a-luger/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.